How much does Erdafitinib cost?

Erdafitinib (Erdafitinib) is a targeted therapy used to treat advanced or metastatic urothelial carcinoma (UC). Urothelial carcinoma is a malignant tumor affecting the urinary tract system, including the bladder, urethra, and renal pelvis. The approval of erdafitinib was primarily based on its excellent efficacy in clinical trials.

Erdafitinib is not currently available in the country, so patients cannot purchase it domestically and need to purchase erdafitinib through foreign channels. The original drug of erdafitinib is mainly the Hong Kong version of the original drug, with a price of more than 20,000, and needs to be purchased through a Hong Kong pharmacy. The generic drugs are relatively cheaper, mainly the Laos version and the Bangladesh Yaopin International version, with a price of about 1,000 to 2,000, and the ingredients of the original drug and the generic drug are basically the same.

As a small molecule tyrosine kinase inhibitor, erdafitinib inhibits the growth of cancer cells by targeting aberrant activation of the FGFR (fibroblast growth factor receptor) family. FGFR is overexpressed or mutated in a variety of malignant tumors, promoting abnormal proliferation of cancer cells. Erdafitinib is designed to target this abnormality and block cancer cell survival signaling, thereby inhibiting tumor development.

Clinical trial results show that erdafitinib has achieved significant efficacy in the treatment of patients with advanced urothelial cancer. For some patients, erdafitinib not only provides a clear survival advantage but also improves quality of life. However, like all drugs, erdafitinib comes with a range of possible side effects, including high blood pressure, fatigue, joint pain, and more.

While using erdafitinib, patients need to closely monitor their physical condition and undergo necessary examinations regularly. The doctor will determine the best treatment plan based on the patient's specific situation and medical history. In addition, patients should maintain active communication while using the drug and promptly report any symptoms of discomfort to the doctor so that the treatment plan can be adjusted in a timely manner.